**Core Concept:** Radiosensitizers are substances that increase the effectiveness of ionizing radiation in killing cancer cells by enhancing the ionization of cellular components, leading to increased DNA damage and ultimately cell death. This can be either by direct interaction with radiation or by enhancing the cellular response to DNA damage.

**Why the Correct Answer is Right:** Mitomycin C (Option D) is a chemotherapy agent primarily used in the treatment of several cancers, including bladder, breast, esophageal, and ovarian cancers. It interferes with DNA synthesis by binding to DNA and cross-linking adjacent bases, inhibiting the replication process and causing cell death. Mitomycin C is not a radiosensitizer because it primarily works as a cytotoxic agent through DNA cross-linking, not by enhancing the cellular response to radiation.

**Why Each Wrong Option is Incorrect:**

A. Mitomycin C is not considered as a radiosensitizer because it primarily works through DNA cross-linking and inhibition of DNA synthesis, not by enhancing the cellular response to radiation.
B. Mitomycin C is not a radiosensitizer because it works primarily as a cytotoxic agent through DNA cross-linking and not by enhancing cellular response to radiation.
C. Mitomycin C is not a radiosensitizer because it primarily inhibits DNA synthesis through cross-linking, not by enhancing cellular response to radiation.

**Clinical Pearl:** Understanding the mechanisms by which different chemotherapy agents work is essential for selecting appropriate treatments for cancer patients and knowing when to combine radiation therapy with chemotherapy.

**Correct Answer:** Mitomycin C (Option D) is not considered as a radiosensitizer because it primarily works through DNA cross-linking and inhibition of DNA synthesis, not by enhancing the cellular response to radiation.